Display options
Share it on

PeerJ. 2015 Aug 11;3:e1175. doi: 10.7717/peerj.1175. eCollection 2015.

A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.

PeerJ

Werner J Geldenhuys, Tamara L Guseman, Ilse S Pienaar, Dean E Dluzen, Jesse W Young

Affiliations

  1. Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University (NEOMED) , Rootstown, OH , USA.
  2. Department of Anatomy and Neurobiology, College of Medicine, Northeast Ohio Medical University, (NEOMED) , Rootstown, OH , USA.
  3. Center for Neurodegeneration and Neuroinflammation, Division of Brain Sciences, Department of Medicine, Imperial College London , London , United Kingdom.
  4. Department of Anatomy and Neurobiology, College of Medicine, Northeast Ohio Medical University, (NEOMED) , Rootstown, OH , USA ; Current affiliation: Department of Anatomy, Southern Illinois University School of Medicine , Carbondale, IL , USA.

PMID: 26339553 PMCID: PMC4558067 DOI: 10.7717/peerj.1175

Abstract

Parkinson's disease (PD) is an age-associated neurodegenerative disorder hallmarked by a loss of mesencephalic dopaminergic neurons. Accurate recapitulation of the PD movement phenotype in animal models of the disease is critical for understanding disease etiology and developing novel therapeutic treatments. However, most existing behavioral assays currently applied to such animal models fail to adequately detect and subsequently quantify the subtle changes associated with the progressive stages of PD. In this study, we used a video-based analysis system to develop and validate a novel protocol for tracking locomotor performance in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. We anticipated that (1) treated mice should use slower, shorter, and less frequent strides and (2) that gait deficits should monotonically increase following MPTP administration, as the effects of neurodegeneration become manifest. Video-based biomechanical analyses, utilizing behavioral measures motivated by the comparative biomechanics literature, were used to quantify gait dynamics over a seven-day period following MPTP treatment. Analyses revealed shuffling behaviors consistent with the gait symptoms of advanced PD in humans. Here we also document dramatic gender-based differences in locomotor performance during the progression of the MPTP-induced lesion, despite male and female mice showing similar losses of striatal dopaminergic cells following MPTP administration. Whereas female mice appeared to be protected against gait deficits, males showed multiple changes in gait kinematics, consistent with the loss of locomotor agility and stability. Overall, these data show that the novel video analysis protocol presented here is a robust method capable of detecting subtle changes in gait biomechanics in a mouse model of PD. Our findings indicate that this method is a useful means by which to easily and economically screen preclinical therapeutic compounds for protecting against or reversing neuropathology associated with PD neurodegeneration.

Keywords: Behavior; Gait; Gender-bias; Locomotion; MPTP

References

  1. Neurotoxicol Teratol. 1996 Sep-Oct;18(5):603-6 - PubMed
  2. JAMA. 2014 Apr 23-30;311(16):1670-83 - PubMed
  3. J Neurosci Methods. 1997 Apr 25;73(1):45-8 - PubMed
  4. Lancet. 2014 Aug 9;384(9942):523-31 - PubMed
  5. Chembiochem. 2014 Jul 8;:null - PubMed
  6. Gait Posture. 2013 Sep;38(4):790-4 - PubMed
  7. Pharmacol Biochem Behav. 2010 Jun;95(4):466-72 - PubMed
  8. Gait Posture. 2014 Jul;40(3):357-62 - PubMed
  9. Neurosci Biobehav Rev. 2013 Jun;37(5):846-59 - PubMed
  10. Front Neuroendocrinol. 2014 Aug;35(3):370-84 - PubMed
  11. J Neurosci Methods. 2002 Jan 30;113(2):123-30 - PubMed
  12. Horm Behav. 1994 Mar;28(1):16-28 - PubMed
  13. Mov Disord. 2011 May;26(6):993-1002 - PubMed
  14. Brain Res Brain Res Protoc. 1997 Dec 1;2(1):75-84 - PubMed
  15. BMC Neurosci. 2012 Nov 14;13:142 - PubMed
  16. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S237-40 - PubMed
  17. Parkinsonism Relat Disord. 2014 Oct;20(10 ):1071-5 - PubMed
  18. Dialogues Clin Neurosci. 2004 Sep;6(3):281-93 - PubMed
  19. Am J Epidemiol. 2003 Jun 1;157(11):1015-22 - PubMed
  20. Exp Neurol. 2014 Jun;256:105-16 - PubMed
  21. J Neuroeng Rehabil. 2005 Jul 25;2:20 - PubMed
  22. Am J Phys Anthropol. 2012 Apr;147(4):580-92 - PubMed
  23. Neuroscience. 2012 Jun 1;211:51-76 - PubMed
  24. J Neural Transm (Vienna). 2001;108(11):1263-82 - PubMed
  25. FEBS J. 2012 Apr;279(7):1156-66 - PubMed
  26. Science. 1965 Nov 5;150(3697):701-8 - PubMed
  27. Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316 - PubMed
  28. Anat Rec (Hoboken). 2014 Oct;297(10):1839-64 - PubMed
  29. Behav Neurosci. 1998 Oct;112(5):1218-28 - PubMed
  30. J Parkinsons Dis. 2011;1(1):19-33 - PubMed
  31. Brain. 1999 Jul;122 ( Pt 7):1271-82 - PubMed
  32. Endocrine. 2003 Jun;21(1):67-75 - PubMed
  33. Neurosci Biobehav Rev. 2012 Nov;36(10):2305-24 - PubMed
  34. Brain. 2013 Feb;136(Pt 2):374-84 - PubMed
  35. Mamm Genome. 2011 Aug;22(7-8):401-19 - PubMed
  36. Mol Neurobiol. 2016 Apr;53(3):1625-36 - PubMed
  37. Neurobiol Dis. 2015 Feb;74:392-405 - PubMed

Publication Types